Preston, Ioana R <br/><br/>
Temporary treatment interruptions with oral selexipag in pulmonary arterial hypertension: Insights from the Prostacyclin (PGI  [electronic resource] 

 -  The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation  03 2018 
 - 401-408 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3117 
<br/><br/><label>Standard No.: </label>10.1016/j.healun.2017.09.024  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetamides--administration & dosage<br/>Administration, Oral<br/>Antihypertensive Agents--administration & dosage<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Hypertension, Pulmonary--drug therapy<br/>Male<br/>Middle Aged<br/>Pyrazines--administration & dosage<br/>Receptors, Epoprostenol--agonists<br/>Time Factors<br/>Withholding Treatment--statistics & numerical data